General cellular lipid synthesis and metabolic pathways

General cellular lipid synthesis and metabolic pathways encompass the complex network of biochemical processes responsible for the creation, degradation, and transformation of lipids within a cell. These pathways include fatty acid synthesis, cholesterol biosynthesis, and the formation of complex lipids like phospholipids and triglycerides, which are essential for membrane integrity, energy storage, and signaling [StatPearls]. Dysregulation of these pathways is a hallmark of numerous metabolic disorders, including obesity, type 2 diabetes, and atherosclerosis, as well as certain cancers where lipid reprogramming supports rapid proliferation [Nature Reviews Molecular Cell Biology]. While not a single therapeutic target, specific enzymes and receptors within these pathways, such as HMG-CoA reductase and Peroxisome proliferator-activated receptors (PPARs), are major focuses of pharmacological intervention [PubChem]. Targeting these pathways allows for the management of dyslipidemia and associated cardiovascular risks [Mayo Clinic]. However, because lipids are fundamental to nearly all cellular functions, systemic modulation can lead to side effects such as muscle toxicity or liver enzyme elevations [NIH LiverTox].

Other names

Lipid metabolismLipogenesisLipid biosynthesisFatty acid metabolismLipid homeostasis

Pharmacological agents typically target specific rate-limiting enzymes (e.g., HMG-CoA reductase) or nuclear receptors (e.g., PPARs) within these pathways to inhibit synthesis, enhance clearance, or alter the distribution of lipids.